author-photo

Karl Anton Kreuzer

University of Cologne
University of Bonn
Humboldt University of Berlin

212

Papers

7476

Citations

Citation Trend

Filter By

Papers (144) Sort By

Journal Conference Others

VENETOCLAX-OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION-BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
GENETIC MARKERS AND OUTCOME WITH FRONT LINE OBINUTUZUMAB PLUS EITHER CHLORAMBUCIL OR VENETOCLAX - UPDATED ANALYSIS OF THE CLL14 TRIAL

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
BENDAMUSTINE, FOLLOWED BY OBINUTUZUMAB, ACALABRUTINIB AND VENETOCLAX IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2‐BAAG TRIAL OF THE GCLLSG

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)

2020
Show All
- Source
- Cite
- Save
Citations (12)
Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicentre, open-label phase-II trial

2020 Haematologica
Show All
- Source
- Cite
- Save
Citations (4)
High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia.

2020 Blood
Show All
- Source
- Cite
- Save
Citations (14)
Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

2020 Cochrane Database of Systematic Reviews
Show All
- Source
- Cite
- Save
Citations (9)
Bendamustine, Followed by Ofatumumab and Ibrutinib in Chronic Lymphocytic Leukaemia (CLL2-BIO): Primary Endpoint Analysis of a Multicentre, Open-Label Phase-II Trial

2019 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)